Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuron ; 37(1): 121-33, 2003 Jan 09.
Article in English | MEDLINE | ID: mdl-12526778

ABSTRACT

Here we describe a novel mechanism for plasma membrane insertion of the delta opioid receptor (DOR). In small dorsal root ganglion neurons, only low levels of DORs are present on the cell surface, in contrast to high levels of intracellular DORs mainly associated with vesicles containing calcitonin gene-related peptide (CGRP). Activation of surface DORs caused Ca(2+) release from IP(3)-sensitive stores and Ca(2+) entry, resulting in a slow and long-lasting exocytosis, DOR insertion, and CGRP release. In contrast, membrane depolarization or activation of vanilloid and P2Y(1) receptors induced a rapid DOR insertion. Thus, DOR activation induces a Ca(2+)-dependent insertion of DORs that is coupled to a release of excitatory neuropeptides, suggesting that treatment of inflammatory pain should include blockade of DORs.


Subject(s)
Cell Membrane/metabolism , Exocytosis/physiology , Ganglia, Spinal/metabolism , Neurons, Afferent/metabolism , Nociceptors/metabolism , Receptors, Opioid, delta/metabolism , Animals , Calcitonin Gene-Related Peptide/metabolism , Calcium/metabolism , Calcium Signaling/drug effects , Calcium Signaling/physiology , Cell Membrane/drug effects , Cell Membrane/ultrastructure , Exocytosis/drug effects , Fluorescent Antibody Technique , Ganglia, Spinal/drug effects , Ganglia, Spinal/ultrastructure , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Mice, Inbred C57BL , Microscopy, Electron , Neurons, Afferent/drug effects , Neurons, Afferent/ultrastructure , Neuropeptides/metabolism , Nociceptors/drug effects , Nociceptors/ultrastructure , PC12 Cells , Pain/metabolism , Pain/physiopathology , Rats , Receptors, Drug/drug effects , Receptors, Drug/metabolism , Receptors, Neurotransmitter/drug effects , Receptors, Neurotransmitter/metabolism , Receptors, Opioid, delta/drug effects , Receptors, Purinergic P2/drug effects , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2Y1 , Secretory Vesicles/metabolism , Secretory Vesicles/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...